Sartar Therapeutics
Developing treatment for soft tissue sarcomas
Developing treatment for soft tissue sarcomas
Sartar Therapeutics develops treatment for soft tissue sarcomas. The focus of cancer therapy is moving towards personalised medicine. There is a clear unmet need to find new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have run out of all currently available options.
There is no investment information
No recent news or press coverage available for Sartar Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
